• 1
    Touraine JL, Betuel H, Souillet G, Jeune M. Combined immunodeficiency disease associated with absence of cell surface HLA-A and B antigens. J Pediatr 1978; 93:47 51.
  • 2
    Moins-Teisserenc HT, Gadola SD, Cella M et al. Association of a syndrome resembling Wegener's granulomatosis with low surface expression of HLA class I-molecules. Lancet 1999; 354:1598 603.
  • 3
    Teisserenc H, Schmitt W, Blake N, Dunbar R, Gadola S, Gross WL, Exley A, Cerundolo V. A case of primary immunodeficiency due to a defect of the major histocompatibility gene complex class I processing and presentation pathway. Immunol Letters 1997; 57:183 7.
  • 4
    De la Salle H, Hanau D, Fricker D et al. Homozygous human TAP peptide transporter mutation in HLA class I deficiency. Science 1994; 265:237 41.
  • 5
    Donato L, De la Salle H, Hanau D, Tongio MM, Oswald M, Vandevenne A, Geisert J. Association of HLA class I antigen deficiency related to a TAP2 gene mutation with familial bronchiectasis. J Pediatr 1995; 127:895 900.
  • 6
    Zimmer J, Donato L, Hanau D, Cazenave JP, Tongio MM, Moretta A, De la Salle H. Activity and phenotype of natural killer cells in peptide transporter (TAP)-deficient patients (type 1 bare lymphocyte syndrome). J Exp Med 1998; 187:117 22.
  • 7
    Zimmer J, Donato L, Hanau D, Cazenave JP, Moretta A, Tongio MM, De la Salle H. Inefficient protection of human TAP-deficient fibroblasts from autologous NK cell-mediated lysis by cytokines inducing HLA class I expression. Eur J Immunol 1999; 29:1286 91.
  • 8
    Maeda H, Hirata R, Chen RF, Suzaki H, Kudoh S, Tohyama H. Defective expression of HLA class I antigens: a case of the bare lymphocyte syndrome without immunodeficiency. Immunogenetics 1985; 21:549 58.
  • 9
    Watanabe S, Iwata M, Maeda H, Ishibashi Y. Immunohistochemical studies of major histocompatibility antigens in a case of the bare lymphocyte syndrome without immunodeficiency. J Am Acad Dermatol 1987; 17:895 902.
  • 10
    Sugiyama Y, Mada H, Okumura K, Takaku F. Progressive sinobronchiectasis associated with the ‘bare lymphocyte syndrome’ in an adult. Chest 1986; 89:398 401.
  • 11
    Furukawa H, Yabe T, Watanabe K et al. Tolerance of NK and LAK activity for HLA class I-deficient targets in a TAP1-deficient patient (bare lymphocyte syndrome type 1). Human Immunol 1999; 60:32 40.
  • 12
    Furukawa H, Murata S, Yabe T et al. Splice acceptor site mutation of the transporter associated with antigen processing-1 gene in human bare lymphocyte syndrome. J Clin Invest 1999; 103:649 52.
  • 13
    Furukawa H, Yabe T, Akaza T et al. Cell surface expression of HLA-E molecules on PBMC from a TAP1-deficient patient. Tissue Antigens 1999; 53:292 5.
  • 14
    Plebani A, Monafo V, Cattaneo R et al. Defective expression of HLA class I and CD1a molecules in a boy with Marfan-like phenotype and deep skin ulcers. J Am Acad Dermatol 1996; 35:814 28.
  • 15
    De la Salle H, Zimmer J, Fricker D et al. HLA class I deficiencies due to mutations in subunit 1 of the peptide transporter TAP1. J Clin Invest 1999; 103:R9 13.
  • 16
    Lepage V, Colombani J, Hors J et al. Decrease of HLA antigen expression in two cases of combined immunodeficiency (CID). Abstract 14.2.15 of the Fourth International Congress of Immunology, Paris. 1980.
  • 17
    Touraine JL. The bare lymphocyte syndrome: report on the registry. Lancet 1981; 1:319 21.
  • 18
    Schuurman RKB, Van Rood JJ, Vossen JM, Schellekens PTA, Feltkamp-Vroom TM, Doyer E, Gmelig-Meyling F, Visser HKA. Failure of lymphocyte-membrane HLA-A and -B expression in two siblings with combined immunodeficiency. Clin Immunol Immunopathol 1979; 14:418 34.
  • 19
    Payne R, Brodsky F, Peterlin BM, Young LM. Bare lymphocytes without immunodeficiency. Hum Immunol 1983; 6:219 27.
  • 20
    Sullivan KE, Stobo JD, Peterlin BM. Molecular analysis of the bare lymphocyte syndrome. J Clin Invest 1985; 76:75 79.
  • 21
    Pamer E & Cresswell P. Mechanisms of MHC class I-restricted antigen processing. Annu Rev Immunol 1998; 16:323 58.
  • 22
    Colonna M. Specificity and function of immunoglobulin superfamily NK cell inhibitory and stimulatory receptors. Immunol Rev 1997; 155:127 33.
  • 23
    Lanier LL & Phillips JH. Inhibitory MHC class I receptors on NK cells and T cells. Immunol Today 1996; 17:86 91.
  • 24
    Braud VM, Allan DSJ, O'Callaghan CAO et al. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 1998; 391:795 9.
  • 25
    Ljunggren HG & Karre K. In search of the ‘missing self’: MHC molecules and NK cell recognition. Immunol Today 1990; 11:237 44.
  • 26
    Kisielow P, Teh HS, Blutmann H, Von Boehmer H. Positive selection of antigen specific T cells in the thymus by restricting MHC molecules. Nature 1988; 335:730 3.
  • 27
    Cerundolo V, Braud V., Browning M, McMichael eds. HLA and MHC genes, molecules, and function. Oxford: Bios Scientific Publisher Ltd, 1996: 193 223.
  • 28
    Williams DB & Watts TH. Molecular chaperones in antigen presentation. Curr Opin Immunol 1995; 7:77 84.
  • 29
    Hughes EA & Cresswell P. The thiol oxidoreductase ERp57 is a component of the MHC class I peptide-loading complex. Curr Biol 1998; 8:709 12.
  • 30
    Morrice NA & Powis SJ. A role for the thiol-dependent reductase ERp57 in the assembly of MHC class I molecules. Curr Biol 1998; 8:713 6.
  • 31
    Sadasivan B, Lehner PJ, Ortmann B, Spies T, Cresswell P. Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class molecules with TAP. Immunity 1996; 5:103 14.
  • 32
    Townsend A, Ohlen C, Bastin J, Ljunggren HG, Foster L, Karre K. Association of class I major histocompatibility heavy and light chains induced by viral peptides. Nature 1989; 340:443 8.
  • 33
    Cerundolo V, Alexander J, Anderson K, Lamb C, Cresswell P, McMichael A, Gotch F, Townsend A. Presentation of viral antigen controlled by a gene in the major histocompatibility complex. Nature 1990; 345:449 52.
  • 34
    Gross WL. Wegener's granulomatosis. In: MadisonPJ, IsenbergDA, WooP, GlassDN, eds. Oxford textbook of rheumatology. Oxford: Oxford University Press, 1998: 2:1331 51.
  • 35
    Wolff SM. Midline granuloma. In: IsselbacherKJ, BraunwaldE, WilsonJD, MartinJB, FauciAS, KasperDL, eds. Harrisons's principles of internal medicine, 13th edn. New York: McGraw-Hill 1994: 294:1686 7.
  • 36
    Martinez-Taboada VM, Blanco R, Garcia-Fuentes M, Rodriguez-Valverde V. Clinical features and outcome of 95 patients with hypersensitivity vasculitis. Am J Med 1997; 102:186 91.
  • 37
    Curnutte JT & Babior BM. Chronic granulomatous disease, a heterogeneous syndrome. Adv Hum Genet 1986; 19:229 97.
  • 38
    Liese JG, Jendrossek V, Jansson A, Petropoulou T, Kloos S, Gahr M, Belohradsky H. Chronic granulomatous disease in adults. Lancet 1995; 346:220 3.
  • 39
    Mechanic LJ, Dikman S, Cunningham-Rundles C. Granulomatous disease in common variable immunodeficiency. Ann Intern Med 1997; 127:613 7.
  • 40
    Cunningham-Rundles C. Clinical and immunologic analyses of 103 patients with common variable immunodeficiency. J Clin Immunol 1989; 9:22 23.
  • 41
    Fauci AS, Haynes BF, Kath P, Wolff S. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983; 98:76 85.
  • 42
    Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, Rottem M, Fauci A. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992; 116:488 98.
  • 43
    DeRemee RA. Sarcoidosis. Mayo Clin Proc 1995; 70:177 81.
  • 44
    Behar SM, Dascher CC, Grusby MJ, Wang CR, Brenner MB. Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis. J Exp Med 1999; 189:1973 80.
  • 45
    Boucher RC. Cystic fibrosis. In: IsselbacherKJ, BraunwaldE, WilsonJD, MartinJB, FauciAS, KasperDL, eds. Harrisons's principles of internal medicine, 13th edn. New York: McGraw-Hill 1994: 222:1194 7.
  • 46
    Weinberger SE. Bronchiectasis and broncholithiasis. In: IsselbacherKJ, BraunwaldE, WilsonJD, MartinJB, FauciAS, KasperDL, eds. Harrisons's principles of internal medicine, 13th edn. New York: McGraw-Hill 1994: 221:1191 4.
  • 47
    Fleming MC, Gewurz AT, Pearson RW. Caseating cutaneous granulomas in a patient with X-linked infantile hypogammaglobulinemia. J Am Acad Dermatol 1991; 24:629 33.
  • 48
    Drolet BA, Drolet B, Zvulunov A, Jacobsen R, Troy J, Esterly NB. Cutaneous granulomas as a presenting sign in ataxia-telangiectasia. Dermatology 1997; 194:273 5.
  • 49
    Takashima T, Ihnishi K, Tsuyuguchi I, Kishimoto S. Differential regulation of formation of multinucleated giant cells from concanavalin A-stimulated human blood monocytes by IFN-gamma and IL-4. J Immunol 1993; 150:3002 10.
  • 50
    Schild H, Mavaddat N, Litzenberger C et al. The nature of major histocompatibility complex recognition by γδ T cells. Cell 1994; 76:29 37.
  • 51
    Tay CH, Szomolanyi-Tsuda E, Welsh RM. Control of infections by NK cells. Curr Top Microbiol Immunol 1998; 230:193 220.
  • 52
    De la Salle H, Houssaint E, Peyrat MA et al. Human peptide transporter deficiency: importance of HLA-B in the presentation of TAP-independent EBV antigens. J Immunol 1997; 158:4555 63.